Price Chart

Headline
Wire
Time (ET)
DATE TIME TYPE PERIOD REPORTED
EPS
ESTIMATED
EPS
SURPRISE
08/04/2022* -- Results Q2 2022 -- -0.09 --
08/04/2022* 16:30 EST Earnings Call Q2 2022 -- -- --
05/05/2022 -- Results Q1 2022 -0.11 -0.08 -46.67%
05/05/2022 16:30 EST Earnings Call Q1 2022 -- -- --
03/01/2022 -- Results Q4 2021 -0.08 -0.07 -23.08%
03/01/2022 16:30 EST Earnings Call Q4 2021 -- -- --
11/04/2021 -- Results Q3 2021 -0.07 -0.06 -23.52%
11/04/2021 16:30 EST Earnings Call Q3 2021 -- -- --
*Estimated Date/Time

Earnings

Next Report Date 08/04/2022 (est.)
EPS Estimate Upgrade
Last Actual EPS Upgrade

Loading chart...
Last Report Date 05/05/2022
Beat/Miss Upgrade
Return Since -3.57%
Last FQE 03/31/2022
Next FQE 06/30/2022

Profile

Edit
Bionano Genomics Inc is a life sciences instrumentation company in the genome analysis space. It is engaged in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes.
URL https://www.bionanogenomics.com
Investor Relations URL https://ir.bionanogenomics.com/
HQ State/Province California
Sector Healthcare
Industry Diagnostics & Research
Equity Style Small Cap/Value
Next Earnings Release Aug. 04, 2022 (est.)
Last Earnings Release May. 05, 2022
Next Ex-Dividend Date N/A
Last Ex-Dividend Date N/A

Dividends

Dividend Per Share (TTM) --
2017
2018
2019
2020
2021
No data available
 
6.00%
4.00%
2.00%
 
Yield to Market 0.00
Yield to Sector 0.00
Yield to Industry 0.00
Last Dividend Amt. --
Dividend Frequency --
Last Ex-Dividend Date --
Yield (TTM) 0.00%
Forward Yield --
Payout Ratio 0.00%
Cash Payout Ratio 0.00%
Consistent Payer (5Y) No
Consistent Growth (5Y) No

Ownership

Insider Ownership Percentage Upgrade
Jul '20
Nov '20
Mar '21
 
80.00%
40.00%
10.00%
 

Short Interest

Short Interest Upgrade
Percent of Shares Outstanding Short Upgrade
Jul '20
Nov '20
Mar '21
 
80.00%
40.00%
10.00%
 

Total Returns Comparison

Edit comparables

Annual Total Returns Versus Peers

Edit comparables
Loading chart...
Name
2015
2016
2017
2018
2019
2020
2021
YTD
--
--
--
--
-76.34%
148.4%
-2.92%
-45.82%
1.38%
11.96%
21.83%
-4.38%
31.49%
18.40%
28.71%
-17.31%
-4.26%
-27.25%
-46.23%
72.53%
22.95%
-80.07%
-34.05%
-16.76%
-68.18%
-52.29%
22.75%
-95.69%
-90.20%
251.9%
148.6%
-44.84%
-67.80%
-28.59%
-49.84%
-47.69%
-93.17%
229.0%
-48.60%
-8.70%
-87.17%
63.37%
16.67%
-79.93%
-17.17%
8.91%
-45.97%
-41.58%
As of June 24, 2022.

Profile

Edit
Bionano Genomics Inc is a life sciences instrumentation company in the genome analysis space. It is engaged in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes.
URL https://www.bionanogenomics.com
Investor Relations URL https://ir.bionanogenomics.com/
HQ State/Province California
Sector Healthcare
Industry Diagnostics & Research
Equity Style Small Cap/Value
Next Earnings Release Aug. 04, 2022 (est.)
Last Earnings Release May. 05, 2022
Next Ex-Dividend Date N/A
Last Ex-Dividend Date N/A

Ownership

Insider Ownership Percentage Upgrade
Jul '20
Nov '20
Mar '21
 
80.00%
40.00%
10.00%
 

Short Interest

Short Interest Upgrade
Percent of Shares Outstanding Short Upgrade
Jul '20
Nov '20
Mar '21
 
80.00%
40.00%
10.00%
 

Top Fund Holders

Symbol Dollars Invested % Weight
TYNE 94308.00 USD 6.07%

Top Portfolio Holders

0 of 0

Other Resources

Whale Wisdom 13F Filings
Seeking Alpha Call Transcripts
Morningstar Insider Trading
Nasdaq Institutional Ownership
Nasdaq Option Chain
SEC SEC Filings
Twitter BNGO Tweets